Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients.
Click here for original story, NIH clinical trial shows remdesivir accelerates recovery from advanced COVID-19
Source: ScienceDaily